Bellin and two other graduates of the biotechnology master’s program, Joel Andrade MS ’21 and Hannah Hirou MS ’23, are ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Eledon Pharma says two type 1 diabetes patients achieved a 'functional cure' after islet transplants backed by its experimental immunosuppressant.